| dbo:abstract
|
- Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK. (de)
- Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. Eivind Kolding succeeded Henrik Gürtler as CEO on 1 May 2014. Eivind Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO for the organisation. Since 2016 Kasim Kutay has been the CEO of Novo Holdings A/S. (en)
|
| dbo:assets
| |
| dbo:foundingYear
| |
| dbo:keyPerson
| |
| dbo:subsidiary
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 26464 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
|
- (Approx. $93.73 billion ) (en)
- 6.97E11
|
| dbp:foundation
| |
| dbp:homepage
| |
| dbp:industry
|
- Asset management (en)
- Life Sciences (en)
|
| dbp:keyPeople
|
- Lars Rebien Sørensen (en)
- Kasim Kutay (en)
|
| dbp:locationCity
| |
| dbp:locationCountry
| |
| dbp:logo
|
- Novo Holdings logo.svg (en)
|
| dbp:name
| |
| dbp:services
|
- Investments in Life Science (en)
|
| dbp:subsid
| |
| dbp:type
|
- Private limited company (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK. (de)
- Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. (en)
|
| rdfs:label
|
- Novo Holdings (de)
- Novo Holdings A/S (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:employer
of | |
| is dbo:parentCompany
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:employer
of | |
| is dbp:parent
of | |
| is foaf:primaryTopic
of | |
